This inventor holds 2 USPTO granted patents. Top assignees: Chugai Seiyaku Kabushiki Kaisha, Maruha Corporation, Osaka Bioscience Institute. Active years: 2008-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 987 
1 out of 17 
1 out of 19 Years Active: 2008-2013
Title: Satoru Takeda: Innovator in Cancer Research and Pregnancy Health
Introduction
Satoru Takeda is a notable inventor based in Saitama, Japan. He has made significant contributions to the fields of cancer research and maternal health. With a total of 2 patents, his work focuses on innovative methods for detecting and treating critical health conditions.
Latest Patents
One of Takeda's latest patents is related to cancer-associated antigen analogue peptides and their uses. This invention addresses the detection of ovarian cancer antigen-specific T cells in the peripheral blood of ovarian cancer patients. By utilizing an experimental system that identifies combinations of CD4 and IL-4 or IFN-γ, Takeda and his team confirmed the presence of these T cells. They discovered that antigen-specific CD4-positive T cells are present at an average frequency of about 4% in the peripheral mononuclear cells of both patients and healthy subjects. Furthermore, they analyzed the epitope for T cells in the core protein MUC 16 of the ovarian cancer-associated antigen CA 125, identifying the amino acid sequence FTLNFTITN as a shorter epitope. Additionally, they found that the analogue peptide OVCA11: GHTAPGPLLVPFTLNFTITN is suitable for T cell activation.
Another significant patent by Takeda is a method for predicting pregnancy-induced hypertension (PIH). This method allows for the precise detection of abnormalities that occur before the onset of PIH, which were previously undetectable by conventional testing methods. It also includes a method for evaluating fetal and placental functions in PIH and involves measuring the level of human lipocalin-type prostaglandin D synthase (L-PGDS) in a body fluid sample collected from a subject.
Career Highlights
Throughout his career, Satoru Takeda has worked with prominent organizations such as Maruha Corporation and Osaka Bioscience Institute. His experience in these institutions has contributed to his expertise in the fields of cancer research and maternal health.
Collaborations
Takeda has collaborated with notable colleagues, including Hiroshi Oda and Kosuke Seiki. These partnerships have further enhanced his research and innovation efforts.
Conclusion
Satoru Takeda's contributions to cancer research and pregnancy health through his innovative patents demonstrate his commitment to advancing medical science. His work not only addresses
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile